Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 4
1994 5
1995 3
1996 2
1997 5
1998 8
1999 5
2000 7
2001 5
2002 2
2005 1
2006 3
2007 4
2008 4
2009 4
2010 2
2011 5
2012 4
2013 6
2014 1
2015 3
2016 10
2017 9
2018 2
2019 4
2020 3
2021 8
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Results by year

Filters applied: . Clear all
Page 1
Integrated mutational landscape analysis of uterine leiomyosarcomas.
Choi J, Manzano A, Dong W, Bellone S, Bonazzoli E, Zammataro L, Yao X, Deshpande A, Zaidi S, Guglielmi A, Gnutti B, Nagarkatti N, Tymon-Rosario JR, Harold J, Mauricio D, Zeybek B, Menderes G, Altwerger G, Jeong K, Zhao S, Buza N, Hui P, Ravaggi A, Bignotti E, Romani C, Todeschini P, Zanotti L, Odicino F, Pecorelli S, Ardighieri L, Bilguvar K, Quick CM, Silasi DA, Huang GS, Andikyan V, Clark M, Ratner E, Azodi M, Imielinski M, Schwartz PE, Alexandrov LB, Lifton RP, Schlessinger J, Santin AD. Choi J, et al. Among authors: ravaggi a. Proc Natl Acad Sci U S A. 2021 Apr 13;118(15):e2025182118. doi: 10.1073/pnas.2025182118. Proc Natl Acad Sci U S A. 2021. PMID: 33876771 Free PMC article.
Finding the junction between claudins and endometrial carcinoma.
Capoferri D, Bignotti E, Ravaggi A, Mitola S, Romani C. Capoferri D, et al. Among authors: ravaggi a. Biochim Biophys Acta Rev Cancer. 2023 Nov;1878(6):189019. doi: 10.1016/j.bbcan.2023.189019. Epub 2023 Nov 10. Biochim Biophys Acta Rev Cancer. 2023. PMID: 37951482 Free article. Review.
Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma.
Ravaggi A, Capoferri D, Ardighieri L, Ghini I, Ferrari F, Romani C, Bugatti M, Zanotti L, Vrede S, Tognon G, Pijnenborg JMA, Sartori E, Calza S, Bignotti E, Odicino F. Ravaggi A, et al. Cancers (Basel). 2022 Nov 3;14(21):5429. doi: 10.3390/cancers14215429. Cancers (Basel). 2022. PMID: 36358847 Free PMC article.
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma.
Romani C, Capoferri D, Reijnen C, Lonardi S, Ravaggi A, Ratti M, Bugatti M, Zanotti L, Tognon G, Sartori E, Odicino F, Calza S, Pijnenborg JMA, Bignotti E. Romani C, et al. Among authors: ravaggi a. Int J Cancer. 2022 Aug 15;151(4):637-648. doi: 10.1002/ijc.34035. Epub 2022 May 10. Int J Cancer. 2022. PMID: 35429348 Free PMC article.
A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer.
Ratner ES, Keane FK, Lindner R, Tassi RA, Paranjape T, Glasgow M, Nallur S, Deng Y, Lu L, Steele L, Sand S, Muller RU, Bignotti E, Bellone S, Boeke M, Yao X, Pecorelli S, Ravaggi A, Katsaros D, Zelterman D, Cristea MC, Yu H, Rutherford TJ, Weitzel JN, Neuhausen SL, Schwartz PE, Slack FJ, Santin AD, Weidhaas JB. Ratner ES, et al. Among authors: ravaggi a. Oncogene. 2012 Oct 18;31(42):4559-66. doi: 10.1038/onc.2011.539. Epub 2011 Dec 5. Oncogene. 2012. PMID: 22139083 Free PMC article.
Transcriptional Characterization of Stage I Epithelial Ovarian Cancer: A Multicentric Study.
Calura E, Ciciani M, Sambugaro A, Paracchini L, Benvenuto G, Milite S, Martini P, Beltrame L, Zane F, Fruscio R, Marchette MD, Borella F, Tognon G, Ravaggi A, Katsaros D, Bignotti E, Odicino F, D'Incalci M, Marchini S, Romualdi C. Calura E, et al. Among authors: ravaggi a. Cells. 2019 Dec 1;8(12):1554. doi: 10.3390/cells8121554. Cells. 2019. PMID: 31805750 Free PMC article.
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial.
Gurizzan C, Lorini L, Paderno A, Tomasoni M, Zigliani G, Bozzola A, Ardighieri L, Battocchio S, Bignotti E, Ravaggi A, Romani C, De Cecco L, Serafini MS, Miceli R, Bardellini E, Majorana A, Piazza C, Bossi P. Gurizzan C, et al. Among authors: ravaggi a. BMC Cancer. 2021 May 17;21(1):561. doi: 10.1186/s12885-021-08297-3. BMC Cancer. 2021. PMID: 34001010 Free PMC article.
Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes.
Ardighieri L, Missale F, Bugatti M, Gatta LB, Pezzali I, Monti M, Gottardi S, Zanotti L, Bignotti E, Ravaggi A, Tognon G, Odicino F, Calza S, Missolo-Koussou Y, Ries CH, Helft J, Vermi W. Ardighieri L, et al. Among authors: ravaggi a. Front Immunol. 2021 Jun 18;12:690201. doi: 10.3389/fimmu.2021.690201. eCollection 2021. Front Immunol. 2021. PMID: 34220848 Free PMC article.
117 results